PTCH1 and nevoid basal cell carcinoma syndrome: The high detection rate of PTCH1 mutations in NBCCS patients enables molecular diagnostics to become a valuable tool for establishing an early diagnosis, especially in the case of atypical phenotype and for yet unaffected family members.